Literature DB >> 7848365

Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

K Pyörälä1, G De Backer, I Graham, P Poole-Wilson, D Wood.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7848365     DOI： 10.1016/0021-9150(94)90200-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  27 in total

1.  Guidelines on preventing cardiovascular disease in clinical practice.

Authors:  R Jackson
Journal:  BMJ       Date:  2000-03-11

2.  2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.

Authors:  Jin Zhang; Li-na Zhang; Dong-mei Chen; Yan-yun Fu; Feng Zhang; Ling-ling Yang; Chun-mei Xia; Hao-wen Jiang; Chun-lan Tang; Zhi-fu Xie; Fan Yang; Jia Li; Jie Tang; Jing-ya Li
Journal:  Acta Pharmacol Sin       Date:  2015-03-16       Impact factor: 6.150

Review 3.  Families of patients with premature coronary heart disease: an obvious but neglected target for primary prevention.

Authors:  C K Chow; A C H Pell; A Walker; C O'Dowd; A F Dominiczak; J P Pell
Journal:  BMJ       Date:  2007-09-08

4.  The pathomorphological alterations of endocardial endothelium in experimental diabetes and diabetes associated with hyperlipidemia.

Authors:  D Popov; A Sima; D Stern; M Simionescu
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

Review 5.  Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia.

Authors:  J C Adkins; D Faulds
Journal:  Drugs       Date:  1997-10       Impact factor: 9.546

6.  Using disease risk estimates to guide risk factor interventions: field test of a patient workbook for self-assessing coronary risk.

Authors:  J Michael Paterson; Hilary A Llewellyn-Thomas; C David Naylor
Journal:  Health Expect       Date:  2002-03       Impact factor: 3.377

Review 7.  [Goals and practical implementation of lipid therapy in coronary heart disease].

Authors:  F U Beil; E Windler
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

8.  [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].

Authors:  José M A Lobos Bejarano; Miguel Angel Royo-Bordonada; Carlos Brotons; Luís Alvarez-Sala; Pedro Armario; Antonio Maiques; Dídac Mauricio; Susana Sans; Fernando Villar; Angel Lizcano; Antonio Gil-Núñez; Fernando de Alvaro; Pedro Conthe; Emilio Luengo; Alfonso Del Río; Olga Cortés; Ana de Santiago; Miguel A Vargas; Mercedes Martínez; Vicenta Lizarbe
Journal:  Aten Primaria       Date:  2009-07-15       Impact factor: 1.137

Review 9.  The potential role of soluble fibre in the treatment of hypercholesterolaemia.

Authors:  A J Coats
Journal:  Postgrad Med J       Date:  1998-07       Impact factor: 2.401

Review 10.  Co-morbidity index in rheumatoid arthritis: time to think.

Authors:  Yasser El Miedany
Journal:  Clin Rheumatol       Date:  2015-10-26       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.